N Toubassi
Biographic Data
| ID | 6067423 |
|---|---|
| NAME | N Toubassi |
| GIVEN NAMES | N |
| FAMILY NAME | Toubassi |
| SIGNATURE | TOUBASSI N |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 4 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1989 |
| LATEST PUBLICATION YEAR | 1989 |
| H-INDEX | 1 |
A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas
We describe a successful program of poliomyelitis control using a combination of killed and live polio vaccines over a 10-year period in two developing areas, the West Bank and Gaza, adjacent to a relatively developed country, Israel. During the 1970s, immunization using live trivalent oral polio vaccine (OPV) in these areas covered more than 90 percent of the infant population. Nevertheless, the incidence of paralytic polio continued to be high,…
A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas
We describe a successful program of poliomyelitis control using a combination of killed and live polio vaccines over a 10-year period in two developing areas, the West Bank and Gaza, adjacent to a relatively developed country, Israel. During the 1970s, immunization using live trivalent oral polio vaccine (OPV) in these areas covered more than 90 percent of the infant population. Nevertheless, the incidence of paralytic polio continued to be high,…
A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas
We describe a successful program of poliomyelitis control using a combination of killed and live polio vaccines over a 10-year period in two developing areas, the West Bank and Gaza, adjacent to a relatively developed country, Israel. During the 1970s, immunization using live trivalent oral polio vaccine (OPV) in these areas covered more than 90 percent of the infant population. Nevertheless, the incidence of paralytic polio continued to be high,…
Antibody (1 work) · Biology (1 work) · Celiac Disease Research and Management (1 work) · Developing country (1 work) · Environmental health (1 work) · Immunization (1 work) · Immunology (1 work) · Immunology (1 work) · Incidence (geometry) (1 work) · Medicine (1 work)